Objective breast density measurement and its impact on breast imaging are among the key abstracts that were presented at the European Congress of Radiology (ECR) meeting, March 7 to March 11. According to Matakina International, six abstracts highlight the use of Volpara objective breast density measurement software to help overcome the limitations of mammography for women with dense breasts. Volpara was also recently selected for use in the European Union (EU) collaborative Adapting Breast Cancer Screening Strategy Using Personalised Risk Estimation (ASSURE) research project.
In one of these exhibits, titled “This is what volumetric breast density is,” Gisella Gennaro, MD, illustrates how volumetric breast density can be measured on digital mammograms and describes potential clinical applications. Showing quantitative breast density results for more than 500 women from Padua, Italy, Gennaro concludes that volumetric breast density has potential to become helpful in tailoring patient workups, in order to overcome limitations in mammography for highly dense breasts.
Cleared by the FDA, HealthCanada, the TGA, and CE-marked, Volpara is in use at sites across the globe. Volpara generates objective, automatic measurement of volumetric breast density and a FDA-cleared BI-RADS breast density category. Volpara supports most of the major digital mammography systems, can be displayed on digital mammography and PACS workstations and be integrated into mammography reporting systems.
